These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 26529383)

  • 1. Dose-response-time modelling: Second-generation turnover model with integral feedback control.
    Andersson R; Jirstrand M; Peletier L; Chappell MJ; Evans ND; Gabrielsson J
    Eur J Pharm Sci; 2016 Jan; 81():189-200. PubMed ID: 26529383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenging the dose-response-time data approach: Analysis of a complex system.
    Andersson R; Jirstrand M; Almquist J; Gabrielsson J
    Eur J Pharm Sci; 2019 Feb; 128():250-269. PubMed ID: 30453011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatments.
    Andersson R; Kroon T; Almquist J; Jirstrand M; Oakes ND; Evans ND; Chappel MJ; Gabrielsson J
    J Pharmacokinet Pharmacodyn; 2017 Jun; 44(3):203-222. PubMed ID: 28224315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint feedback analysis modeling of nonesterified fatty acids in obese Zucker rats and normal Sprague-Dawley rats after different routes of administration of nicotinic acid.
    Tapani S; Almquist J; Leander J; Ahlström C; Peletier LA; Jirstrand M; Gabrielsson J
    J Pharm Sci; 2014 Aug; 103(8):2571-84. PubMed ID: 24986056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges of a mechanistic feedback model describing nicotinic acid-induced changes in non-esterified fatty acids in rats.
    Ahlström C; Peletier LA; Gabrielsson J
    J Pharmacokinet Pharmacodyn; 2013 Aug; 40(4):497-512. PubMed ID: 23824920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions.
    Ahlström C; Kroon T; Peletier LA; Gabrielsson J
    J Pharmacokinet Pharmacodyn; 2013 Dec; 40(6):623-38. PubMed ID: 24114415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feedback modeling of non-esterified fatty acids in rats after nicotinic acid infusions.
    Ahlström C; Peletier LA; Jansson-Löfmark R; Gabrielsson J
    J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):1-24. PubMed ID: 21046209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing profile profoundly influences nicotinic acid's ability to improve metabolic control in rats.
    Kroon T; Kjellstedt A; Thalén P; Gabrielsson J; Oakes ND
    J Lipid Res; 2015 Sep; 56(9):1679-90. PubMed ID: 26168997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turnover modeling of non-esterified fatty acids in rats after multiple intravenous infusions of nicotinic acid.
    Isaksson C; Gabrielsson J; Wallenius K; Peletier LA; Toreson H
    Dose Response; 2009 Apr; 7(3):247-69. PubMed ID: 19809543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of rate and extent of tolerance of biomarkers: application to nicotinic acid-induced changes in non-esterified fatty acids in rats.
    Ahlström C; Peletier LA; Gabrielsson J
    Eur J Pharm Sci; 2011 Oct; 44(3):250-64. PubMed ID: 21856416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response-time data analysis involving nonlinear dynamics, feedback and delay.
    Gabrielsson J; Peletier LA
    Eur J Pharm Sci; 2014 Aug; 59():36-48. PubMed ID: 24751673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinic acid timed to feeding reverses tissue lipid accumulation and improves glucose control in obese Zucker rats[S].
    Kroon T; Baccega T; Olsén A; Gabrielsson J; Oakes ND
    J Lipid Res; 2017 Jan; 58(1):31-41. PubMed ID: 27875257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute dose-dependent disposition studies of nicotinic acid in rats.
    Iwaki M; Ogiso T; Hayashi H; Tanino T; Benet LZ
    Drug Metab Dispos; 1996 Jul; 24(7):773-9. PubMed ID: 8818575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free fatty acid turnover and oxidation after burn shock in guinea pigs.
    Robinson KM; Miller HI
    Circ Shock; 1981; 8(3):283-90. PubMed ID: 6788397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists.
    Carballo-Jane E; Gerckens LS; Luell S; Parlapiano AS; Wolff M; Colletti SL; Tata JR; Taggart AK; Waters MG; Richman JG; McCann ME; Forrest MJ
    J Pharmacol Toxicol Methods; 2007; 56(3):308-16. PubMed ID: 17643322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acid.
    Dhalla AK; Santikul M; Smith M; Wong MY; Shryock JC; Belardinelli L
    J Pharmacol Exp Ther; 2007 Apr; 321(1):327-33. PubMed ID: 17204748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic modeling of the antilipolytic effects of an adenosine receptor agonist in healthy volunteers.
    Zannikos PN; Rohatagi S; Jensen BK
    J Clin Pharmacol; 2001 Jan; 41(1):61-9. PubMed ID: 11144995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed Effects Modeling Using Stochastic Differential Equations: Illustrated by Pharmacokinetic Data of Nicotinic Acid in Obese Zucker Rats.
    Leander J; Almquist J; Ahlström C; Gabrielsson J; Jirstrand M
    AAPS J; 2015 May; 17(3):586-96. PubMed ID: 25693487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of substrate utilization, manipulated by nicotinic acid, on excess postexercise oxygen consumption.
    Trost S; Wilcox A; Gillis D
    Int J Sports Med; 1997 Feb; 18(2):83-8. PubMed ID: 9081262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.